BioDelivery Tech Used to Deliver Flu-Targeting siRNAs; Company Eyes Other RNAi Approaches

/Home/Biologics Delivery - Protein Synthesis/RNA - Protein Synthesis/RNAi - Protein Synthesis

BioDelivery Tech Used to Deliver Flu-Targeting siRNAs; Company Eyes Other RNAi Approaches
By Doug Macron
August 10, 2006
RNAi News
The preclinical work was conducted by an undisclosed partner. However, the collaborator?s interest in RNAi-based flu drugs may provide a clue to its identity.
Paid subscription is required to view article.